[Quantum Neuroimaging Industry, Alzheimerâ€™s](https://www.chemicalqdevice.com/quantum-neuroimaging-industry-alzheimers) PDF + Discussion 2/2/23.

ChemicalQDevice Newsletter #50 is in the comments. The Mission Statement is a foundation for Startup activity. A quantum-based Stage I Alzheimer's Analysis Algorithm MVP is expected Q3 2023, details can be found in the attached deck.

#1 Apple, #2 FDA, and #3 AWS: Kevin Kawchak's most frequent company viewers in recent weeks.

Event Registrations include colleagues from Apple, AWS, Deloitte, and more. There have been 68 consecutive weekly discussions regarding quantum and/or medical technologies between Oct 2021 and Feb 2023. Prominent investment bankers have offered to meet recently. 

Thank you for your continued interest in ChemicalQDevice.

-- <br>
Have a good weekend, <br>
CEO Kevin Kawchak <br>
ChemicalQDevice <br>
February 3rd, 2023 <br>
